Calcium Channel Blockers in African American Hypertension Management

Primary Recommendation

• The American College of Cardiology recommends calcium channel blockers (CCBs), particularly amlodipine, as first-line therapy for hypertension in African American patients, either as monotherapy or in combination with thiazide-type diuretics, as they demonstrate superior blood pressure lowering and cardiovascular event reduction compared to renin-angiotensin system (RAS) inhibitors in this population 1, 2

Initial Therapy Selection

• CCBs are equally effective as thiazide diuretics (chlorthalidone) in reducing blood pressure, cardiovascular disease, and stroke events in African Americans 1, 2

Combination Therapy Strategy

• The American Heart Association suggests that optimal combinations for African Americans include CCB + thiazide diuretic (most effective combination) 1, 2, 3
• The American College of Cardiology recommends CCB + ARB (alternative effective combination) 3, 4

Special Populations

• The American College of Cardiology recommends CCBs or thiazide diuretics as first-line therapy for African Americans with diabetes (without nephropathy), as RAS inhibitors offer no advantage over these agents in diabetic patients without nephropathy 1, 2
• The American College of Cardiology suggests that if proteinuria is present in African Americans with chronic kidney disease, ACE inhibitor or ARB must be included in the regimen (but does not need to be initial therapy) 1, 2, 6

Blood Pressure Targets

• The American College of Cardiology recommends a blood pressure target of <140/90 mmHg for African Americans with diabetes or CKD 1, 5, 6

Critical Clinical Pearls

• The American College of Cardiology notes that most African Americans require ≥2 medications to achieve blood pressure control 1, 2, 4
• The American Heart Association suggests reassessing blood pressure within 3 months of initiating or changing therapy 3, 7